In got a little more info today. Catalysts coming up:
1. Blackrock Investment filed 13G yesterday. They now own almost 10 million shares of STSI. They have almost 6% ownership. A 13G filing is when A passive individual investor can file an initial SC 13G within 10 days of acquiring 5% ownership, and must file annually within 45 days of the end of the calendar year to report any changes in ownership. If the change in ownership exceeds 10% or changes by more than 5% then an amended 13G is required within 10 days.
2. By Feb 15th 1 or 2 more 13G filings will be occuring I have been told. What this means as retail investors having been selling the institutions have been buying over the last couple of months.
3. Dr. Mullan the new CEO and Dr. Chapman the new President are the real deal. Dr. Mullan has more experience with anatabine then anyone. Dr. Chapman has pushed dozens of drugs thru trials and FDA approval. He has never not had a drug approved.
4. They just sent the letter back today to the FDA on the questions of anatabine as a nutraceutical. I don't have a copy but, what I have been told they clearly state that anatabine the soon to be drug version is completely different as anatabine the nutraceutical. Not sure of the timeline on what FDA will say about anatabloc being sold as nutraceutical.
5. They will be submitting the Investigational New Drug Application within the next 2-3 weeks. FDA has 30-60 days to accept this. Once it's accepted they can move forward with Phase III studies on the diseases I have talked about in the past(MS, Thyroid, Chrohn's, IBD, Arthritis, and eventually alzheimer's).
6. They have been in talks for awhile with partners(i.e. Big pharma & Bio-tech Companies) to licensing technology and to move forward with Phase III Studies. This will happen sooner rather than later. I don't have any more specific info.
7. Investor conf will be sometime in March done at Roskamp Institute. I will be attending this. After that they will be going on road shows to get more institutions and funds to invest. I'm estimating that somewhere by mid Feb once the 13G filings are complete that Institutions and Insiders will own more than 60% of the outstanding shares. Institutional ownership is increasing.
8. Rosacea Study is due out in the next week or two. They will plan to license this out. FDA more relaxed on regulation of cosmetic industry.
9. Alzheimer's Study being done by Roskamp Institute and overseen by Dr. Michael Mullan will be completed later this year.
10. Been told in the future have been in talks with tobacco companies about at some point licensing anatabine for ECigarette's.
AI
